Ads
related to: psa 2 area on agingagingcare.com has been visited by 10K+ users in the past month
- Speak To An Advisor Today
Our service is always free. Get
free home care advice today.
- Find A Home Health Aide
Share your care needs and get local
options to compare. Search today.
- Compare Costs & Services
Get free estimates and compare care
options on price and availability.
- In Home Care Locator
Use our Home Care Agency Locator
to find local agencies near you
- Caregivers Near You
Our free service will help you find
the right care for your family.
- Find In-Home Care
Share your needs & get Home Care
options to compare. Search today.
- Speak To An Advisor Today
Search results
Results From The WOW.Com Content Network
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
Used in conjunction with a PSA test, the PSE test boosts accuracy from 55% to 94% offering a more effective and precise method for detecting and diagnosing prostate cancer. [45] The 4Kscore combines total, free and intact PSA together with human kallikrein 2. [46] It is used to try to determine the risk of a Gleason score greater than 6. [46]
Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.Abnormal growth of prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA) levels.
What Your PSA Test Results Mean. THE PSA IS a good initial “check engine light” for the prostate, says Garrett Pohlman, M.D., a urologist and host of The Prostate Health Podcast. But it can ...
Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.
It appears to provide more accuracy in identifying early prostate cancer than the standard prostate cancer marker, PSA. "EPCA-2" is not the name of a gene. EPCA-2 gets its name because it is the second prostate cancer marker identified by the research team. This earlier marker was previously known as "EPCA", [1] [2] but is now called "EPCA-1".
Ad
related to: psa 2 area on agingagingcare.com has been visited by 10K+ users in the past month